DK0975362T3 - Farmaceutisk sammensætning eller fødevaresammensætning til behandling af patologiske tilstande knyttet til transplantatafstødning, allergiske eller autoimmune reaktioner - Google Patents

Farmaceutisk sammensætning eller fødevaresammensætning til behandling af patologiske tilstande knyttet til transplantatafstødning, allergiske eller autoimmune reaktioner

Info

Publication number
DK0975362T3
DK0975362T3 DK98909232T DK98909232T DK0975362T3 DK 0975362 T3 DK0975362 T3 DK 0975362T3 DK 98909232 T DK98909232 T DK 98909232T DK 98909232 T DK98909232 T DK 98909232T DK 0975362 T3 DK0975362 T3 DK 0975362T3
Authority
DK
Denmark
Prior art keywords
allergic
treatment
conditions associated
pathological conditions
graft rejection
Prior art date
Application number
DK98909232T
Other languages
English (en)
Inventor
Jean Duchateau
Genevieve Servais
Original Assignee
Biotech Tools Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech Tools Sa filed Critical Biotech Tools Sa
Application granted granted Critical
Publication of DK0975362T3 publication Critical patent/DK0975362T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
DK98909232T 1997-03-05 1998-03-05 Farmaceutisk sammensætning eller fødevaresammensætning til behandling af patologiske tilstande knyttet til transplantatafstødning, allergiske eller autoimmune reaktioner DK0975362T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE9700199A BE1011033A6 (fr) 1997-03-05 1997-03-05 Composition pharmaceutique et/ou alimentaire pour le traitement de pathologies liees a un rejet de greffe, une reaction allergique ou auto-immune ou du cancer.
PCT/BE1998/000030 WO1998039029A2 (fr) 1997-03-05 1998-03-05 Composition pharmaceutique ou alimentaire pour le traitement de pathologies liees a un rejet de greffe, une reaction allergique ou auto-immune

Publications (1)

Publication Number Publication Date
DK0975362T3 true DK0975362T3 (da) 2003-11-10

Family

ID=3890389

Family Applications (2)

Application Number Title Priority Date Filing Date
DK03017072.4T DK1354599T3 (da) 1997-03-05 1998-03-05 Farmaceutisk sammensætning eller fødevare til behandling af patologiske tilstande forbundet med afstødning af transplantater
DK98909232T DK0975362T3 (da) 1997-03-05 1998-03-05 Farmaceutisk sammensætning eller fødevaresammensætning til behandling af patologiske tilstande knyttet til transplantatafstødning, allergiske eller autoimmune reaktioner

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK03017072.4T DK1354599T3 (da) 1997-03-05 1998-03-05 Farmaceutisk sammensætning eller fødevare til behandling af patologiske tilstande forbundet med afstødning af transplantater

Country Status (10)

Country Link
US (1) US6312711B1 (da)
EP (2) EP1354599B1 (da)
JP (1) JP4554728B2 (da)
AT (2) ATE246003T1 (da)
BE (1) BE1011033A6 (da)
CA (1) CA2283143C (da)
DE (2) DE69841966D1 (da)
DK (2) DK1354599T3 (da)
ES (2) ES2354941T3 (da)
WO (1) WO1998039029A2 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6709672B2 (en) * 1997-03-05 2004-03-23 Biotech Tools S.A. Pharmaceutical or food composition for treating pathologies associated with graft rejection or an allergic or autoimmune reaction
AU743647B2 (en) 1998-01-31 2002-01-31 Mt. Sinai School Of Medicine Of New York University Methods and reagents for decreasing allergic reactions
US20020012667A1 (en) * 2000-05-16 2002-01-31 Mcmichael John Method for preventing allograft rejection
EP1286693A4 (en) * 2000-06-02 2005-07-13 Univ Connecticut Health Ct COMPLEXES OF ALPHA (2) MACROGLOBULIN AND ANTIGENIC MOLECULES FOR USE IN IMMUNOTHERAPY
WO2002070005A1 (en) * 2001-02-28 2002-09-12 Immvarx, Incorporated Compositions of multimeric profilin for diagnosis and treatment of allergies
CN1635896A (zh) * 2001-08-20 2005-07-06 康涅狄格大学健康中心 包含用于治疗癌症及感染性疾病的热休克蛋白或α2－巨球蛋白的组合物制备方法
CA2514500A1 (en) * 2003-02-20 2004-09-10 University Of Connecticut Health Center Methods for using compositions comprising heat shock proteins or alpha-2-macroglobulin in the treatment of cancer and infectious disease
US8436136B2 (en) * 2003-05-21 2013-05-07 Biotech Tools S.A. Peptide complex
EP1479689A1 (en) * 2003-05-21 2004-11-24 Biotech Tools S.A. Peptide complex
EP1625148B1 (en) * 2003-05-21 2012-09-26 Biotech Tools S.A. Peptide complex
WO2004112833A1 (en) * 2003-06-23 2004-12-29 Biotech Tools Sa Epitope composition for sublingual, buccal or enteric administration prepared by hydrolysis of antigenic structures with chymotrypsin
DE602004032025D1 (de) * 2003-06-23 2011-05-12 Biotech Tools Sa Epitop-zusammensetzung zur enterischen verabreichung hergestellt durch hydrolyse von antigenen strukturen mit chymotrypsin
WO2010086418A1 (en) * 2009-01-29 2010-08-05 Alfa Biogene International B.V. Functional food product comprising heat shock protein or a hydrolysate thereof
EP2734231A1 (en) 2011-07-21 2014-05-28 Biotech Tools S.A. Dosage of dnak
CN109890414A (zh) 2016-10-05 2019-06-14 Asit生物技术公司 预防过敏

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2171454T3 (es) * 1993-06-04 2002-09-16 Whitehead Biomedical Inst Proteinas de estres y sus usos.
US5961979A (en) * 1994-03-16 1999-10-05 Mount Sinai School Of Medicine Of The City University Of New York Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
BE1008817A6 (fr) 1994-10-28 1996-08-06 Univ Bruxelles Procede d'obtention d'adn bicatenaire membranaire humain, produit obtenu par ce procede et trousse de diagnostic le contenant.
JP3656277B2 (ja) * 1995-05-17 2005-06-08 味の素株式会社 組換えｄｎａ法によるトランスグルタミナーゼの効率的製造法
BE1009359A7 (fr) 1995-05-19 1997-02-04 Univ Bruxelles Procede de detection et/ou de quantification de ligands specifiques d'une pathologie liee a une reponse allergique.
IL123218A0 (en) * 1995-08-18 1998-09-24 Sloan Kettering Inst Cancer Heat shock protein-based vaccines and immunotherapies
JP4484969B2 (ja) * 1996-11-26 2010-06-16 ヌベンタ バイオファーマスティカル コーポレイション ストレスタンパク質を含む組成物を使用する免疫応答
US6017540A (en) * 1997-02-07 2000-01-25 Fordham University Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes

Also Published As

Publication number Publication date
EP1354599A3 (fr) 2003-12-10
JP2001514623A (ja) 2001-09-11
WO1998039029A3 (fr) 1999-01-14
EP1354599B1 (fr) 2010-10-20
EP0975362A2 (fr) 2000-02-02
DE69816796D1 (de) 2003-09-04
EP1354599A2 (fr) 2003-10-22
ATE246003T1 (de) 2003-08-15
ATE485054T1 (de) 2010-11-15
ES2201453T3 (es) 2004-03-16
DE69841966D1 (de) 2010-12-02
CA2283143A1 (fr) 1998-09-11
EP0975362B1 (fr) 2003-07-30
US6312711B1 (en) 2001-11-06
DE69816796T2 (de) 2004-05-27
WO1998039029A2 (fr) 1998-09-11
ES2354941T3 (es) 2011-03-21
CA2283143C (fr) 2014-05-27
DK1354599T3 (da) 2011-02-07
BE1011033A6 (fr) 1999-04-06
JP4554728B2 (ja) 2010-09-29

Similar Documents

Publication Publication Date Title
DK0975362T3 (da) Farmaceutisk sammensætning eller fødevaresammensætning til behandling af patologiske tilstande knyttet til transplantatafstødning, allergiske eller autoimmune reaktioner
DE3874825D1 (de) Vernetzte organopolysiloxane und darauf basierende emulsionen.
FI963101A7 (fi) Anti-TNF-vasta-aineiden käyttö lääkkeenä sellaisten sairauksien hoitoo n, joissa seerumin interleukiini-6-taso on kohonnut
NL192275B (nl) Eiwit van het AIDS-virus.
BR9608199B1 (pt) composição de vacina compreendendo um antìgeno, qs21 e um esterol.
ES2016391B3 (es) Vehiculo de motor con plataforma de carga y carroceria con elementos de plastico, y metodo para su fabricacion.
DE3687769D1 (de) Vakzine und diagnostika, die vom bovine-diarrhea-virus stammen.
DE58907000D1 (de) Korrektur- und haltevorrichtung, insbesondere für die wirbelsäule.
DE3750342D1 (de) Menschliches gamma-interferon-spezifisches Rezeptorprotein, Antikörper gegen dieses Protein, Verfahren zur Herstellung dieses Proteins und dieses Antikörpers und dieses Protein und diesen Antikörper enthaltende Zusammensetzungen.
DE3585953D1 (de) Dna-fragmente, expressionsvektoren, proteine, wirte und verfahren zur herstellung der proteine.
AU5320086A (en) Monoclonal antibodies against core proteins of lymphadenopathy-associated-viruses
IT1231047B (it) Riscaldatore per autoveicoli o simili.
DE68914883D1 (de) Geflügel-Mycoplasma-Antigene und das Gen enthaltende rekombinante Vektoren sowie Diagnostika und Vakzine, die diese verwenden.
ATE221663T1 (de) Prionbindende proteine und deren verwendungen
DE3769418D1 (de) Amidosubstituierte naphthalenen und zwischenstufen dafuer.
DK0772632T3 (da) T-celle-stimulerende protein af pestivirus
NO873767L (no) Fremgangsmaate for bestemmelse av igm- og iga-immunoglobuliner og reagenser for fremgangsmaaten.
ATA28993A (de) Heizeinrichtung für feste brennstoffe, insbesondere kompaktofen bzw. kamineinsatz
DE3750240D1 (de) Gen, das ein Insektizid-Protein kodiert, und Herstellung des Proteins durch Verwendung dieses Gens.
DE68917223D1 (de) Fahrzeugpassagierbestuhlung.
NO893037L (no) Anordning for sjoebunn-understoettelse av plattform-ben, samt plattform med slike anordninger.
DK31589D0 (da) Assay for begyndende diabetes, monoklonale antistoffer til anvendelse herved og saet til anvendelse hertil.
MX9102498A (es) Mezclas de multipolimeros de acrilico modificados con caucho, u policarbonatos; y metodo para la fabricacion de las mismas.
EP0401379A4 (en) Stabilized composition of interleukin-1-g(b)
FR2708695B1 (fr) Support de Moteur.